Tirzepatide

Price range: £45 through £110

Guaranteed Safe And Secure Checkout

Tirzepatide is an investigational peptide specifically developed as a dual receptor agonist, targeting both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. Its combined mechanism of action is of growing interest within research focused on metabolic disorders, obesity, and insulin resistance.

Research Applications:

Emerging data from preclinical and early clinical studies suggest that Tirzepatide may contribute to:

Improved glycaemic control and insulin sensitivity

Reduction in body weight via appetite regulation and delayed gastric emptying.

Enhanced lipid metabolism and reduction in visceral adiposity.

Support for overall metabolic function in obesity-related models.

Important Notice:

This compound is provided exclusively for research purposes by qualified professionals. It is not intended for human or animal use, nor for therapeutic, diagnostic, or consumable applications.